More specifically pertaining to Alzheimer’s disease, ghrelin has been shown to enhance insulin sensitivity and reduce abnormal tau phosphorylation of hippocampal neurons [183], as well as modulate the production of inflammatory cytokines induced by β-amyloid fibrils in microglia [184]. The gene discussed is GHRL; the disease is early-onset autosomal dominant Alzheimer disease.